Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency

NCT01213043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Emphysema
Alpha 1-antitrypsin Deficiency (AATD)

Interventions

BIOLOGICAL: Prolastin-C, 60 mg/kg
BIOLOGICAL: Prolastin-C, 120 mg/kg

Sponsor

Grifols Therapeutics LLC